In summary, extensive research highlights the crucial role of LRRC8A, an essential component of VRACs, in central nervous system conditions such as epilepsy and stroke, suggesting it as a promising target for therapeutic interventions in neurological disorders. Here, LRRC8A is linked to stroke disorder.